Saltar al contenido
Merck

542334

IGEPAL® CO-630

average Mn 617

Sinónimos:

Éter de nonilfenil polioxietileno (9), ramificado

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño



About This Item

Fórmula lineal:
(C2H4O)n · C15H24O · n=9-10
Número CAS:
UNSPSC Code:
12162002
NACRES:
NA.23
MDL number:

Nombre del producto

IGEPAL® CO-630, average Mn 617

mol wt

average Mn 617

bp

250 °C (lit.)

density

1.056 g/mL at 25 °C (lit.)

HLB

13

Quality Level

Application

Tensioactivo no iónico

General description

IGEPAL® CO-630 es un etoxilato alquilfenol utilizado fundamentalmente como tensioactivo aniónico. Pertenece a la serie de tensioactivos IGEPAL, que tienen cadenas hidrófobas. Entre sus propiedades se cuentan una baja tensión superficial, baja sensibilidad, y biocompatibilidad.

Legal Information

IGEPAL is a registered trademark of Solvay

pictograms

Environment

signalword

Warning

hcodes

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1

Clase de almacenamiento

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What physical form is Product 542334, IGEPAL® CO-630?

    This product is a liquid.

  5. What is the concentration of Product 542334, IGEPAL® CO-630?

    Based on a reported density of 1.056 g/mL at 25 °C(lit.), and a reported average molecular weight of Mn ~617. The approximate molar concentration is 1.7 M.

  6. What is the cloud point of Product 542334, IGEPAL® CO-630?

    The cloud point of a 1% solution is 52°C-56°C.

  7. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  8. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Preparation of highly concentrated stable dispersions of uniform silver nanoparticles
Sondi I, et al.
Journal of Colloid and Interface Science, 260(1), 75-81 (2003)
Wetting of TX-100 and Igepal CO-630 Surfactants on a PTFE Surface
Biswal NR and Paria S
Industrial & Engineering Chemistry Research, 50(10), 6138-6145 (2011)
Wettability of a PTFE surface by cationic-non-ionic surfactant mixtures in the presence of electrolytes
Chaudhuri RG, et al.
Soft Matter, 8(20), 5429-5433 (2012)
Viktorija Herceg et al.
Molecules (Basel, Switzerland), 25(18) (2020-09-24)
Cyclopeptidic chemotherapeutic prodrugs (cPCPs) are macromolecular protease-sensitive doxorubicin (DOX) prodrugs synthesized from a cyclodecapeptidic scaffold, termed Regioselectively Addressable Functionalized Template (RAFT). In order to increase the chemotherapeutic potential of DOX and limit its toxicity, we used a Cathepsin B (Cat
Mirko Trilling et al.
Journal of virology, 83(8), 3684-3695 (2009-02-13)
Vaccinia virus (VACV) replicates in mouse and human fibroblasts with comparable kinetics and efficiency, yielding similar titers of infectious progeny. Here we demonstrate that gamma interferon (IFN-gamma) but not IFN-alpha or IFN-beta pretreatment of mouse fibroblasts prior to VACV infection

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico